Cancer
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
| PAR-22-239 | Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed) | HHS-NIH11 | 10/26/2022 | 01/06/2023 |
| RFA-ES-22-007 | Utilizing Telomere Status to Reveal Molecular Mechanisms Underlying Susceptibility and Resiliency in Response to Environmental Exposures (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 10/21/2022 | 02/14/2023 |
| RFA-CA-22-056 | Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 10/03/2022 | 12/15/2023 |
| RFA-CA-22-057 | Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 10/03/2022 | 12/15/2023 |
| RFA-CA-22-036 | NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) | HHS-NIH11 | 09/15/2022 | 02/28/2023 |
| RFA-CA-22-035 | NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) | HHS-NIH11 | 09/15/2022 | 02/28/2023 |
| RFA-CA-22-037 | NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) | HHS-NIH11 | 09/15/2022 | 02/28/2023 |
| RFA-CA-22-050 | NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) | HHS-NIH11 | 09/01/2022 | 02/06/2024 |
| RFA-OH-23-001 | Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) | HHS-CDC-HHSCDCERA | 08/29/2022 | 12/06/2022 |
| RFA-CA-22-041 | The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) | HHS-NIH11 | 08/18/2022 | 11/18/2022 |
| RFA-CA-22-045 | NCI Outstanding Investigator Award (R35 Clinical Trial Optional) | HHS-NIH11 | 07/26/2022 | 11/07/2024 |
| PAR-22-218 | Biology of Bladder Cancer (R01 Clinical Trial Optional) | HHS-NIH11 | 07/26/2022 | 09/07/2025 |
| PAR-22-219 | Biology of Bladder Cancer (R21 Clinical Trial Optional) | HHS-NIH11 | 07/26/2022 | 09/07/2025 |
| PAR-22-216 | NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) | HHS-NIH11 | 07/14/2022 | 07/01/2025 |
| PAR-22-173 | Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) | HHS-NIH11 | 06/23/2022 | 09/07/2025 |
| PAR-22-199 | Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional) | HHS-NIH11 | 06/14/2022 | 09/07/2025 |
| PAR-22-165 | Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) | HHS-NIH11 | 06/13/2022 | 09/07/2025 |
| PAR-22-164 | Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) | HHS-NIH11 | 06/13/2022 | 09/07/2025 |
| PAR-22-187 | NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) | HHS-NIH11 | 05/25/2022 | 11/02/2022 |
| PAR-22-188 | NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) | HHS-NIH11 | 05/25/2022 | 11/02/2022 |
| RFA-CA-22-027 | Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional) | HHS-NIH11 | 05/12/2022 | 09/29/2023 |
| PAR-22-131 | Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) | HHS-NIH11 | 04/12/2022 | 09/07/2025 |
| PAR-22-136 | Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) | HHS-NIH11 | 04/11/2022 | 06/17/2024 |
| RFA-CA-22-021 | Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) | HHS-NIH11 | 03/24/2022 | 11/17/2022 |
| PAR-22-140 | Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 03/18/2022 | 05/07/2025 |
| PAR-22-139 | Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 03/18/2022 | 05/07/2025 |
| PAR-22-114 | Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) | HHS-NIH11 | 02/25/2022 | 01/23/2025 |
| PAR-22-086 | Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 02/18/2022 | 05/07/2025 |
| PAR-22-085 | Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 02/18/2022 | 05/07/2025 |
| PAR-22-084 | Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 01/21/2022 | 05/07/2025 |
| PAR-22-099 | Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) | HHS-NIH11 | 01/21/2022 | 05/07/2025 |
| PAR-22-083 | Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 01/21/2022 | 05/07/2025 |
| PAR-22-071 | Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 11/23/2021 | 11/17/2024 |
| PAR-22-062 | Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 11/03/2021 | 01/07/2025 |
| PAR-22-061 | Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 11/03/2021 | 01/07/2025 |
| PAR-21-329 | Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) | HHS-NIH11 | 09/22/2021 | 11/05/2024 |
| PAR-21-300 | NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed) | HHS-NIH11 | 09/10/2021 | 09/07/2024 |
| PAR-21-302 | NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) | HHS-NIH11 | 09/10/2021 | 09/07/2024 |
| PAR-21-299 | NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) | HHS-NIH11 | 09/10/2021 | 09/07/2024 |
| RFA-CA-21-020 | National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed) | HHS-NIH11 | 09/01/2021 | 09/28/2023 |
| PAR-21-296 | NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) | HHS-NIH11 | 08/31/2021 | 11/12/2024 |
| PAR-21-295 | NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) | HHS-NIH11 | 08/31/2021 | 11/12/2024 |
| PAR-21-278 | Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) | HHS-NIH11 | 08/26/2021 | 09/07/2024 |
| PAR-21-279 | Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) | HHS-NIH11 | 08/26/2021 | 09/07/2024 |
| PAR-21-294 | Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 07/22/2021 | 09/07/2024 |
| PAR-21-290 | Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) | HHS-NIH11 | 07/22/2021 | 09/07/2024 |
| PAR-21-138 | Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) | HHS-NIH11 | 06/03/2021 | 12/01/2024 |
| PAR-21-138 | Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) | HHS-NIH11 | 06/03/2021 | 12/01/2024 |
| PAR-21-061 | Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 03/18/2021 | 11/17/2023 |
| PAR-21-128 | The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) | HHS-NIH11 | 03/15/2021 | 03/14/2024 |
| PAR-21-318 | The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) | HHS-NIH11 | 03/15/2021 | 03/14/2024 |
| PAR-21-111 | The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) | HHS-NIH11 | 03/15/2021 | 03/14/2024 |
| PAR-21-190 | Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) | HHS-NIH11 | 03/12/2021 | 03/07/2024 |
| RFA-OD-21-004 | Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 03/10/2021 | 03/08/2023 |
| PAR-21-065 | Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) | HHS-NIH11 | 11/17/2020 | 01/07/2024 |
| PAR-21-066 | Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) | HHS-NIH11 | 11/17/2020 | 01/07/2024 |
| PAR-21-067 | Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) | HHS-NIH11 | 11/17/2020 | 01/07/2024 |
| PAR-21-033 | National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | HHS-NIH11 | 11/12/2020 | 01/07/2024 |
| PAR-21-035 | Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) | HHS-NIH11 | 11/10/2020 | 01/07/2024 |
| PAR-20-305 | Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) | HHS-NIH11 | 09/28/2020 | 01/07/2024 |
| PAR-20-303 | Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional) | HHS-NIH11 | 09/04/2020 | 09/07/2023 |
| PAR-20-302 | Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) | HHS-NIH11 | 09/04/2020 | 09/07/2023 |
| PAR-20-284 | Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 08/13/2020 | 05/04/2023 |
|
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) |
HHS-NIH11 |
07/23/2020 |
06/19/2023 |
|
|
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) |
NIH |
05/20/2020 |
05/07/2023 |
|
|
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
NIH |
03/12/2020 |
05/07/2023 |
|
|
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) |
NIH |
01/27/2020 |
05/07/2023 |
|
|
Co-infection and Cancer (R21 Clinical Trial Not Allowed) |
NIH |
11/22/2019 |
01/07/2023 |
|
|
Co-infection and Cancer (R01 Clinical Trial Not Allowed) |
NIH |
11/22/2019 |
01/07/2023 |
|
|
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) |
NIH |
11/12/2019 |
01/07/2023 |
|
|
NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional) |
NIH |
11/08/2019 |
01/07/2023 |
|
|
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) |
NIH |
10/02/2019 |
01/07/2023 |
|
|
Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) |
NIH |
10/02/2019 |
01/07/2023 |
|
|
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) |
NIH |
09/12/2019 |
01/07/2023 |